A new system for measuring the spinal fat lesions in axial spondyloarthritis appears to determine treatment outcomes as accurately as, and sooner than, current methods. This could make new drug trials much more informative.
Internists gain some guidance on identifying systemic lupus erythematosus (SLE) and why they should work with rheumatologists. Meanwhile, two UK studies outline paths to successful gout treatment and lower mortality rates after hip replacement surgery. Finally, the use of imaging, including ultrasound, are refined for diagnosing sarcoidosis.